Friday, 27 September 2013

Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing

Funds to be Used to Advance the Company�s Transformative Touch Activated Phlebotomy� Technology Platform

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)-- Seventh Sense Biosystems, Inc., a company redefining blood sampling and health diagnostic... Devices, Diagnostics, Venture CapitalSeventh Sense Biosystems, Touch Activated Phlebotomy (Source: HSMN NewsFeed)

Source: http://www.medworm.com/index.php?rid=4808256&cid=c_183_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033310

phlebotomy courses online online phlebotomy courses phlebotomy online courses

No comments:

Post a Comment